HELIXBIND | Identification of Bloodstream Infections | Boxborough, MA
HelixBind is developing an innovative diagnostic platform to revolutionize care for bloodstream infections and sepsis. Its proprietary technology delivers faster and more accurate microbiology results within four hours compared to the two-to-three days required by traditional blood culture tests, enabling clinicians to initiate precise antimicrobial treatment sooner. The platform is designed to reduce antimicrobial resistance and improve patient outcomes.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2022
Jan 2020
Jan 2014
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
